Short term treatment with pioglitazone improves adiponectin and intact proinsulin levels in type 2 diabetic patients with coronary heart disease

被引：0
|
作者：
Hohberg, Cloth
Forst, Thomas
Luebben, Georg
Karagiannis, Efstrathios
Schoendorf, Thomas
Pfuetzner, Andreas
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A669 / A669
页数：1
相关论文
共 50 条
  • [21] How to detect atheromatous coronary heart disease in type 2 diabetic patients?
    Varenne, O.
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2008, 101 : 30 - 35
  • [22] Effects of pioglitazone on serum fetuin-A levels in type 2 diabetic patients
    Mori, Katsuhito
    Emoto, Masanori
    Araki, Takahiro
    Lee, Eiko
    Yokoyama, Hisayo
    Teramura, Megumi
    Motoyama, Koka
    Koyama, Hidenori
    Shoji, Tetsuo
    Nishizawa, Yoshiki
    DIABETES, 2007, 56 : A162 - A162
  • [23] High-resolution identification of human adiponectin oligomers and regulation by pioglitazone in type 2 diabetic patients
    Mashalidis, Ellene H.
    Briggs, David B.
    Zhou, Mowei
    Vergara, Ashley M.
    Chhun, Jimmy J.
    Ellsworth, Ronald K.
    Giron, Rebecca M.
    Rood, Jennifer
    Bray, George A.
    Smith, Steven R.
    Wysocki, Vicki H.
    Tsao, Tsu-Shuen
    ANALYTICAL BIOCHEMISTRY, 2013, 437 (02) : 150 - 160
  • [24] A comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea coronary heart disease in type 2 therapy'
    Chang, Yoosoo
    Choi, Nam-Kyong
    Hahn, Seokyung
    Park, Byung-Joo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (10) : 1072 - 1073
  • [25] Lack of association of lipoprotein (a) with coronary heart disease in Spaniard type 2 diabetic patients
    Relimpio, F
    Pumar, A
    Losada, F
    Morales, F
    Acosta, D
    Astorga, R
    DIABETOLOGIA, 1996, 39 : 1034 - 1034
  • [26] ANKLE BRACHIAL INDEX IN THE PREDICTION OF CORONARY HEART DISEASE IN TYPE 2 DIABETIC PATIENTS
    Bouzid, K.
    Ben Ahmed, H.
    Oueslati, I.
    Lahiani, S.
    Khiari, K.
    Khessairi, N.
    Belagha, J.
    Ghezaiel, S.
    Ben Abdallah, N.
    Baccar, H.
    Abdelmoula, J.
    ATHEROSCLEROSIS, 2016, 252 : E140 - E141
  • [27] POLYMORPHISM OF ANGIOTENSINOGEN GENE AND THE RISK OF CORONARY HEART DISEASE IN TYPE 2 DIABETIC PATIENTS
    Likidlilid, A.
    Peerapatdit, T.
    Chantawee, R.
    Tresukosol, D.
    Sriratanasathavorn, C.
    Ratnamaneechat, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 238 - 239
  • [28] Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients
    Tavil, Yusuf
    Sen, Nihat
    Yazici, Hueseyin
    Turfan, Murat
    Hizal, Fatma
    Cengel, Atiye
    Abaci, Adnan
    PLATELETS, 2010, 21 (05) : 368 - 372
  • [29] Lack of association of lipoprotein (a) with coronary heart disease in Spaniard type 2 diabetic patients
    Relimpio, F
    Pumar, A
    Losada, F
    Montilla, C
    Morales, F
    Acosta, D
    Astorga, R
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1997, 35 (2-3) : 135 - 141
  • [30] Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes
    Yaturu, Subhashini
    Daberry, Robert P.
    Rains, Justin
    Jain, Sushil
    CYTOKINE, 2006, 34 (3-4) : 219 - 223
12345